Related references
Note: Only part of the references are listed.MDCK cell-cultured influenza virus vaccine protects mice from lethal challenge with different influenza viruses
Kun Liu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2012)
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production
Emanuele Montomoli et al.
EXPERT REVIEW OF VACCINES (2012)
The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine
Signe C. Svindland et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2012)
The Contribution of Systemic and Pulmonary Immune Effectors to Vaccine-Induced Protection from H5N1 Influenza Virus Infection
Yuk-Fai Lau et al.
JOURNAL OF VIROLOGY (2012)
Cold-Adapted Pandemic 2009 H1N1 Influenza Virus Live Vaccine Elicits Cross-Reactive Immune Responses against Seasonal and H5 Influenza A Viruses
Yo Han Jang et al.
JOURNAL OF VIROLOGY (2012)
Multiple-Clade H5N1 Influenza Split Vaccine Elicits Broad Cross Protection against Lethal Influenza Virus Challenge in Mice by Intranasal Vaccination
Penghui Yang et al.
PLOS ONE (2012)
Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly
Timo Vesikari et al.
VACCINE (2012)
An overview of Influenza A virus receptors
Shengqiang Ge et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2011)
The future of cell culture-based influenza vaccine production
Michael L. Perdue et al.
EXPERT REVIEW OF VACCINES (2011)
Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets
Kortney M. Gustin et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2)
Irina Isakova-Sivak et al.
VIROLOGY (2011)
Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model
J. Theo M. Voeten et al.
ARCHIVES OF VIROLOGY (2010)
Antigenic and Genetic Diversity of Highly Pathogenic Avian Influenza A (H5N1) Viruses Isolated in Egypt
Amanda L. Balish et al.
AVIAN DISEASES (2010)
High Level of Genetic Compatibility between Swine-Origin H1N1 and Highly Pathogenic Avian H5N1 Influenza Viruses
Cassio Pontes Octaviani et al.
JOURNAL OF VIROLOGY (2010)
Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
Nathalie Landry et al.
PLOS ONE (2010)
Current status and progress of prepandemic and pandemic influenza vaccine development
Isabel Leroux-Roels et al.
EXPERT REVIEW OF VACCINES (2009)
Reassortment between Avian H5N1 and Human H3N2 Influenza Viruses in Ferrets: a Public Health Risk Assessment
Sara Jackson et al.
JOURNAL OF VIROLOGY (2009)
H5N1 Vaccine-Specific B Cell Responses in Ferrets Primed with Live Attenuated Seasonal Influenza Vaccines
Xing Cheng et al.
PLOS ONE (2009)
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults
Kawsar R. Talaat et al.
VACCINE (2009)
Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults
Ruth A. Karron et al.
VACCINE (2009)
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials)
Larisa Rudenko et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2008)
Update on Avian Influenza A (H5N1) Virus Infection in Humans
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza a viruses
Li-Mei Chen et al.
PLOS PATHOGENS (2008)
Induction of heterosubtypic immunity to influenza virus by intranasal immunization
Fu-Shi Quan et al.
JOURNAL OF VIROLOGY (2008)
Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus
Timothy J. Powell et al.
JOURNAL OF IMMUNOLOGY (2007)
Avian influenza virus (H5N1): a threat to human health
J. S. Malik Peiris et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential
J. A. Desheva et al.
VACCINE (2006)
Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses
Xiuhua Lu et al.
VACCINE (2006)
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets
Amorsolo L. Suguitan et al.
PLOS MEDICINE (2006)
Origin and evolution of highly pathogenic H5N1 avian influenza in Asia
LD Sims et al.
VETERINARY RECORD (2005)
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine
I Stephenson et al.
VIRUS RESEARCH (2004)
Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines
RJ Cox et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics
K Subbarao et al.
VIROLOGY (2003)
A DNA transfection system for generation of influenza A virus from eight plasmids
E Hoffmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
